|
End-of-day quote
Prague S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 110.00 CZK | -3.51% |
|
-5.58% | -35.29% |
| 06-14 | Pilulka Lékárny a.s. Auditor Raises 'Going Concern' Doubt | CI |
| 06-14 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 298M 13.8M 12.18M 11.53M 10.45M 19.6M 1.32B 19.79M 138M 53.29M 676M 51.84M 50.71M 2.18B | P/E 2024 |
-2.31x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 337M 15.64M 13.81M 13.06M 11.85M 22.21M 1.5B 22.43M 157M 60.39M 767M 58.74M 57.46M 2.47B | EV / Sales 2024 |
0.25x | EV / Sales 2025 | 0.57x |
| Free-Float |
49.9% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.51% | ||
| 1 week | -5.58% | ||
| Current month | -2.65% | ||
| 3 months | -3.93% | ||
| Current year | -35.29% |
| 1 week | 110 |  | 114 |
| 1 month | 110 | | 118 |
| Current year | 99 | | 177 |
| 1 year | 99 | | 190 |
| 3 years | 80 | | 420 |
| 5 years | 80 | | 1,800 |
| 10 years | 80 | | 1,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Kasa
PRN | Corporate Officer/Principal | 46 | 2012-12-31 |
Petr Kasa
CEO | Chief Executive Officer | 49 | 2012-12-31 |
David Stanek
DFI | Director of Finance/CFO | - | 2019-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Miloš Cebík
BRD | Director/Board Member | 46 | 2015-06-24 |
Martin Buchta
CHM | Chairman | 51 | 2020-08-26 |
Marek Krajcovic
BRD | Director/Board Member | 52 | 2020-08-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.51% | -5.58% | -39.89% | -73.62% | 14.38M | |
| -1.22% | -0.89% | -46.38% | -7.86% | 14.45B | |
| -1.24% | -5.05% | -20.19% | -8.61% | 6.22B | |
| +1.06% | +0.88% | -57.06% | -39.92% | 5.85B | |
| +2.40% | +3.65% | -6.50% | -21.27% | 4.06B | |
| -0.27% | -0.22% | -20.98% | -36.93% | 3.16B | |
| +0.38% | +1.23% | -39.59% | -17.26% | 3.03B | |
| +0.34% | +0.45% | +6.64% | -29.11% | 3.01B | |
| -0.15% | -8.93% | +56.04% | - | 2.58B | |
| -0.06% | -1.89% | -27.50% | -14.27% | 2.25B | |
| Average | -0.19% | -1.67% | -19.54% | -27.65% | 4.46B | |
| Weighted average by Cap. | -0.12% | -1.48% | -27.79% | -18.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.3B 60.47M 53.37M 50.49M 45.79M 85.85M 5.8B 86.7M 606M 233M 2.96B 227M 222M 9.54B | 876M 40.64M 35.86M 33.93M 30.77M 57.69M 3.9B 58.26M 407M 157M 1.99B 153M 149M 6.41B |
| Net income | -126M -5.83M -5.15M -4.87M -4.41M -8.28M -559M -8.36M -58.4M -22.51M -286M -21.89M -21.42M -919M | -38.87M -1.8M -1.59M -1.5M -1.36M -2.56M -173M -2.58M -18.05M -6.96M -88.31M -6.77M -6.62M -284M |
| Net Debt | 38.28M 1.77M 1.57M 1.48M 1.34M 2.52M 170M 2.54M 17.78M 6.85M 86.96M 6.66M 6.52M 280M | 39.66M 1.84M 1.62M 1.54M 1.39M 2.61M 176M 2.64M 18.42M 7.1M 90.1M 6.9M 6.75M 290M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | CZK 110.00 | -3.51% | 443 |
| 26-09-25 | CZK 114.00 | +1.79% | 45 |
| 26-09-24 | CZK 112.00 | 0.00% | 52 |
| 26-09-23 | CZK 112.00 | -3.86% | 149 |
- Stock Market
- Stocks
- PINK Stock
Select your edition
All financial news and data tailored to specific country editions
